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ABSTRACT
 
The human body can be exposed to nanomaterials through a 
variety of different routes. As nanomaterials get in contact with 
the skin, the gastrointestinal tract, and the respiratory tract, 
these biological compartments are acting as barriers to the 
passage of nano-sized materials into the organism. These 
structural and functional barriers are provided by the epithelia 
serving as an interface between biological compartments. In 
order to initiate the reduction, refinement and replacement of 
time consuming, expensive and stressful (to the animals) in vivo 
experimental approaches, many in vitro epithelial cell culture 
models have been developed during the last decades. This 
review therefore, focuses on the functional as well as structural 
aspects of epithelial cells as well as the most commonly used in 
vitro epithelial models of the primary biological barriers with 
which nanomaterials might come in contact with either 
occupationally, or during their manufacturing and application. 
The advantages and disadvantages of the different in vitro 
models are discussed in order to provide a clear overview as to 
whether or not epithelial cell cultures are an advantageous 
model to be used for basic mechanism and nanotoxicology 
research. 
 
 
1. INTRODUCTION1
Nanotechnology is a rapidly growing field, 
with the application of engineered 
nanomaterials in daily life is constantly 

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increasing. Nanomaterials are defined by 
the European Commission as materials 
whose main constitutes have a dimension 
between 1 and 100 billionth of a metre 
(http://ihcp.jrc.ec.europa.eu/our_activities
/nanotechnology/what-is-a-nanomaterial-
european-commission-breaks-new-ground-
with-a-common-definition). In the past 
decade there has been a substantial 
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increase in the debate regarding the 
potential harmful effects of nanomaterials 
[1-4], with particular concern expressed as 
to their possible adverse effects to both 
human health and the environment [5]. 
Thus, it is essential that the potential 
toxicity and the mechanism(s) of the 
interaction of nanomaterials with target 
cells that may lead to local and systemic 
(human) health effects [6] are understood. 
Possible cellular reactions such as the 
induction of oxidative stress, (pro-
)inflammatory reactions [7] and 
genotoxicity [8] must be considered for 
such studies. 
The specific routes by which 
nanomaterials may enter the human body, 
and potentially elicit adverse effects are 
the lung via inhalation, the 
gastrointestinal tract via digestion, the 
skin, and blood vessels via intravenous 
injection [4].  As nanomaterials gain 
contact with the skin, the gastrointestinal 
tract, and the respiratory tract, these 
biological compartments are “innately 
designed” to act as barriers to the passage 
of nano-sized materials into the organism 
[9]. Since the epithelium is “the” primary 
structural barrier, the aim of the present 
review is to provide an overview of this 
important anatomical structure as well as 
functional aspects of epithelial cells and 
furthermore to discuss, if in vitro 
epithelial cell cultures of human origins 
are advantageous models for gaining a 
basic understanding of the potential 
human health effects of nanomaterials. 
 
1.1. The epithelium 
The epithelium is besides the connective 
tissue, muscle tissue and nervous tissue 
one of the four types of mammalian 
tissue. Since the epithelium lines all body 
surfaces, cavities and tubes its main 
function is to provide an interface between 
biological compartments. Epithelial cells 
are closely bound to each other and 
supported by the basement membrane 
acting as scaffolding which separates the 
epithelia from the underlying connective 
tissue. Since the epithelium is innervated 
but never penetrated by blood vessels the 
epithelial cells are dependent on the 
diffusion of oxygen and metabolites from 
the underlying tissue.  Epithelia are 
responsible for adsorption, secretion as 
well as protection and they are also often 
arranged into structures called glands 
[10]. 
Epithelial cells form continuous sheets 
within the epithelium which are attached 
to one another at many locations by tight 
junctions, adherens junctions and 
desmosomes [10] (Figure 1A). 

Figure 1: CellͲcell junctions between 16HBE140Ͳ
bronchial epithelial cells. A) Transmission electron
microscopy image showing cellͲcell contacts in
epithelial cells, i.e.  tight junctions,  adherens
junctions, aswell as thedesmosomes (Adapted from
[27]).B)Laserscanningmicrographof16HBE14oͲcells
stainedforthetightjunctionproteinoccludin(yellow),
FͲactincytoskeleton(red)andcellnuclei(green).
Such cell junctions are especially abundant 
in epithelial tissues. Epithelial cells form 
cellular barriers separating compartments 
of different composition. In forming such 
barriers the epithelial cells polarize and 
form intercellular junctions [11-13]. Tight 
junctions separate the epithelium in an 
apical and a basal site and are the most 
apical intercellular junctions [14]. They 
control paracellular transport, as for 
example, preventing macromolecules from 
easily passing through the epithelial layer. 
Besides the proteins forming the tight 
junctions there are also other cell-cell 
associating proteins, such as 
transmembrane proteins (cadherins) of 
adherens junctions, which are linked via 
intracellular proteins (e.g. catenins) to the 
actin cytoskeleton and cell adhesion 
molecules, desmosomes linking 
intracellular keratin cytoskeletal filaments 
to the cell membrane, and gap junction 
proteins (connexins) which are 
communicating junctions [10,15-17]. 
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 1.2. Epithelial cell culture models  
Understanding the functional and 
pathological disorders induced by 
nanomaterials in different barrier systems 
requires the investigation of the direct 
effects of these “xenobiotics” on the state 
(i.e. homeostasis) and activity of cells 
present within such a biological barrier. So 
far, three approaches have been used: in 
vivo experiments, ex vivo studies of cells 
or biopsies isolated from animals,  and in 
vitro cell culture systems to study the 
effect of pollutants under controlled 
conditions [18]. 
The exposure of animals, isolated tissues 
or in vitro cell cultures to nanomaterials 
requires the knowledge and 
understanding of several methodological 
challenges. The advantages and 
disadvantages of each model type need to 
be considered, as it is not possible to 
solve all problems and to answer all 
questions by conducting studies using 
animal models only [19,20]. Despite such 
methodological issues however, to study 
the interaction of nanomaterials with cells  
using in vitro models can be extremely 
powerful [21]. During the last years there 
have been sustained efforts to replace 
animal experiments by cell culture 
approaches in many fields of research. 
One of the major advantages of in vitro 
research is that, compared to animal 
models, cellular and sub-cellular functions 
(i.e. cell growth, cell interactions or 
metabolism, as well as the underlying 
molecular pathways) can be studied with 
ease in a simplified, biological model 
system, provided that the in vitro model is 
established appropriately to focus exactly 
on the mechanism of interest. Cultured 
human and animal cell can be better 
controlled and high standardization 
maximizes reproducibility. One has to 
bear in mind though that cell cultures are 
systems isolated from the normal 
environment and may hence behave in a 
way which is different from the in vivo 
situation. Guidelines for good cell culture 
practice are required, should be applied 
and documented, including the control of 
the starting material (e.g. the cultured 
cells, the culture medium, and the culture 
substratum) [21-23].  
In vitro cell cultures may be established 
from freshly isolated tissue (primary 
cultures) or may stem from a continuous 
cell line (secondary cultures). Both systems 
have advantages and disadvantages. 
Primary cultures isolated from animal 
tissue represent a heterogeneous 
population of different cell types, although 
each isolation is unique and impossible to 
exactly reproduce. Primary cultures face 
the limitations such as the lack of 
availability of normal human airway tissue, 
the limited number of cells which can be 
received during each isolation, and an 
uncertainty due to donor variation [23].  
Cell lines are genetically homogenous and 
more stable than primary cells and, hence, 
welcome to obtain minimal biological 
variation within the experimental setup. 
The disadvantage of cell lines, however, is 
that they retain little phenotypic 
differentiation. Nevertheless, if cell 
cultures are used properly they represent 
a sophisticated and reproducible system 
with which basic and mechanistic 
questions can be answered and which may 
help to understand what occurs within an 
in vivo environment.  
 
1.3. Evaluating the barrier 
characteristics of epithelial cells 
Cultures of mammalian cells can be used 
as the basis for simplified biological 
systems in basic science in order to obtain 
a more controllable and reproducible 
system compared to in vivo models [24]. 
However, if such a biological system is 
simplified to its absolute fundamental 
level, then it is paramount that the 
essential components of such a reduced 
system are clearly defined, understood 
and reproducible [23]. 
Certain biochemical markers can be used 
to make a positive identification of 
epithelial cells. The intermediate filament 
proteins in the cytokeratin group are 
almost exclusively found in epithelial cells, 
and thus, are often used for this purpose 
[24]. In addition, the expression and 
typical localisation of E-cadherin, a tissue 
specific protein expressed at sites of cell-
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cell contact, and which is important for 
the formation of polarized epithelia [25] 
can also be verified to confirm the 
presence of epithelial cells in culture. 
Epithelial cultures can also be screened for 
tight junction proteins or adherens 
junction proteins using a variety of 
methods, such as real-time polymerase 
chain reaction, western blot, immune 
histochemistry and immunofluorescence 
[26,27]. By analyzing the fluorescently 
labelled proteins with laser scanning 
microscopy, combined with deconvolution 
of the dataset, valuable information 
regarding the spatial distribution of these 
proteins can be gained [28]. The cell-cell 
junctions can also be nicely demonstrated 
by transmission electron microscopy as 
shown in 16HBE14o- cells. In Figure 1A 
the junction complex consisting of tight 
and adherens junctions as well as 
desmosomes are well defined as 
determined with transmission electron 
microscopy. Such cells were examined in 
addition by laser scanning micrososcopy 
and the 3D reconstruction of the tight 
junction label showed that occludin was 
expressed at the cell-cell contacts and 
formed the typical belt-like structures 
(Figure 1B). 
Regardless of the in vitro model types 
utilized in transport or translocation 
studies the first priority is to ascertain the 
integrity of the model [29]. As a first step 
towards fulfilling assurance of the 
epithelial cell culture being used, one may 
begin with the measurement of the trans-
epithelial electrical resistance of a given 
model. This method, which uses a pair of 
electrodes, enables the researcher to 
assess the difference in the electrical 
resistance across the epithelium, thus 
providing essential information regarding 
the tightness of the cell-cell contact within 
the epithelium culture. This process is 
mostly applied in a two chamber system, 
where the two chambers are separated by 
the epithelial layer grown on a filter insert. 
Finally the electrical resistance of the filter 
insert without cells is subtracted from the 
value measured with cells and the result is 
multiplied in regards to the surface area 
(as a factor of cm2) of the insert (Figure 
2A). The resulting unit measured is cm2 
for trans-epithelial electrical resistance. 
For instance primary alveolar epithelial 
cultures display values of > 1000 cm2 
[30] and, for bronchial cell lines, values 
ranging between 300 and 400 cm2 have 
been reported [31]. Another method to 
test the epithelial integrity is to measure 
the permeation of the epithelial barrier by 
a paracellular marker (e.g. 14C-mannitol or 
different dextrans) which can be 
characterized by the apparent permeation 
co-efficient. Similar to the trans-epithelial 
electrical resistance evaluation, the 
apparent permeation co-efficient is usually 
determined in a two chamber system in 
which two compartments are separated by 
the model barrier. The compound to be 
studied is added to the donor 
compartment and the apparent 
permeation co-efficient
 
is experimentally 
derived from the time-dependent linear 
increase of the amount of compound in 
the receiver compartment (Figure 2B). 

Figure 2: Measurement of transͲepithelial electrical
resistance in epithelial cell cultures grown in twoͲ
chamber systemsonapermeablemembrane.A)Use
ofapairofelectrodestomeasurethedifferenceinthe
electrical resistance across the epithelium. B)
Determination of the apparent permeation with
DextranͲBlue. The compound is added to the donor
compartment and the apparent permeation coͲ
efficient is experimentally derived from the timeͲ
dependentlinearincreaseoftheamountofcompound
inthereceivercompartment.
Mathematically, the apparent permeation 
co-efficient
 
equals the fictive thickness of a 
buffer layer above the cells which is 
cleared from the compound within the 
indicated time interval; thus, the apparent 
permeation co-efficient represents the 
clearance of the compound divided by the 
area of the insert membrane cultured with 
cells. Numerous set-ups and several 
methods to determine apparent 
permeation co-efficient values are 
available [32]. The apparent permeation 
co-efficient in Madine-Darby canine kidney 
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cell cultures, which reflects a tight 
epithelial barrier, is 1.41 r 0.13 x10-
6cm/sec [33], and for A549 cells 2.25 r 
0.4 x10-6cm/sec [34].  
 
2. Cell culture models
The use of cell cultures of the primary 
barrier systems, i.e. skin, gastro-intestinal 
tract, and skin, are reliable tools to study 
possible effects after exposure of those 
barriers to nanomaterials. After adequate 
characterisation and validation, such 
systems may be valuable alternatives to 
animal experiments. A lot of work to 
assess all the different scientific aims has 
been performed by establishing primary 
cell cultures or immortal cell lines and the 
focus of this review is to summarize the 
most used cell lines within the 
nanotoxicity field. Some ex-vivo systems 
which have been successfully applied for 
nanomaterial research are also mentioned. 
2.1. Epithelial skin cell culture 
models 
The external surface of the skin consists 
of a keratinised squamous epithelium, 
known as the epidermis, which is 
supported and nourished by a thick 
underlying layer of connective tissue 
referred to as the dermis, which is highly 
vascular and contains many sensory 
receptors [10]. A major function of the 
skin, especially the stratum corneum, 
which is the most outer layer, is to provide 
a protective barrier against the hazardous 
external environment. The skin is 
relatively impenetrable to lipophilic 
particles larger than 600 Daltons in size, 
whereas lipophilic particles any smaller 
than this may passively penetrate the skin 
[35]. 
The skin might be exposed to 
nanomaterials present in cosmetic 
products such as moisturisers and 
sunscreens. The skin is also a potential 
target for drug delivery via nano-carriers 
[36]. Nanoparticles (i.e. defined as a nano-
object with all three external dimensions 
in the nanoscale [37]) have unique 
physical properties making them ideal for 
use in various skin care products currently 
on the market. Functionalized and/or 
surface modified metal oxide 
nanoparticles, specifically zinc oxide (ZnO) 
and titanium dioxide (TiO
2
), are the 
primary nanomaterials used in sunscreen 
and skin care products as UV adsorber 
[38]. Most of the studies provide evidence 
that the skin is not the major target of 
nanoparticle delivery [39,40]. However, 
controversial discussions are ongoing 
concerning the benefits of nanoparticles in 
dermatological therapies and skin care 
products, as well as the potential 
disadvantages and possible mechanisms 
of toxicity [41].   
Nano TiO
2
 and ZnO formulated in topically 
applied sunscreen products exist as 
aggregates of primary particles ranging 
from 30 to 150 nm in size. These 
aggregates are bonded in such a way that 
the force of sunscreen product application 
onto the healthy skin would have no 
impact on their structure or result in the 
release of primary particles. Many studies 
using skin tissue (which is easily available 
from animal slaughterhouses) have also 
shown that under exaggerated test 
conditions neither nano-structured TiO
2
 
nor ZnO penetrate beyond the stratum 
corneum of skin using the “minipig” 
species [42]. Studies of the translocation 
of TiO
2
 nanoparticles in histological skin 
sections suggest that these nanoparticles 
may only penetrate into the ‘horny’ upper 
layers of the stratum corneum [43]. 
However, other studies have shown that 
nano-sized particles can enter a small 
percentage of hair follicles and are stored  
in this location for a prolonged period 
compared to their location within the 
stratum corneum; a factor that may 
enhance drug delivery by this route, 
although it will also exacerbate any 
potential toxicity (i.e. dose kinetics) [44]. 
While such studies suggest little, if any 
epidermal or dermal penetration of these 
nanoparticles, recent work in live mice and 
pigs indicates that topically applied nano-
sized TiO
2
 particles (<10 nm) may indeed 
pass through the stratum corneum [45]. In 
addition, stretched porcine skin was far 
more susceptible to dermal translocation 
of a C
60
 fullerene substituted peptide, 
which could reach the intercellular spaces 
of the stratum granulosum in stretched 
skin [46]. 
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Some studies have also been done using 
skin epithelial cell lines, such as the 
epidermal cell line A431. [47].  Another 
example is the immortalized human 
keratinocyte cell line HaCaT [48] which has 
been used to study the effects of silver 
[49], TiO
2
 [50] or SiO
2
 nanoparticles [51], 
just to mention some references.  
Since the epidermis is composed of many 
different cell layers the optimal in vitro 
skin model is still lacking [52] and further 
research needs to be performed. However, 
since complete skin tissue can be easily 
obtained from the slaughterhouse this 
might be a better tool to study 
nanomaterial effects when applied on 
skin. In addition, commercially available 
models such as the EpiDermTM skin model 
(www.mattek.com) as well as the EPISKINTM 
(www.loreal.com) have been evaluated for 
corrosivity testing of chemicals and their 
potential in risk assessment for 
nanomaterials needs to be evaluated more 
thoroughly.  
 
2.2. Epithelial (digestive) gastro-
intestinal tract cell culture models 
Throughout the digestive system the 
lumen is lined with the epithelium which 
changes structure and function according 
to the purpose of the corresponding part. 
The epithelium consists of a one-layer cell 
sheet which is however, altered in height 
and form in the different regions of the 
whole tract [10]. 
Humans continue to evolve with constant 
oral exposure to nanoparticles, such as to 
TiO
2
 (designated E171 in Europe), which is 
used for whitening and brightening foods 
(especially for confectionary), white sauces 
and dressings, and certain powdered food 
products. Particulate silicates and 
aluminosilicates (E554, E556 and E559 in 
Europe) are also used in the food industry 
as anti-caking agents and to allow the flow 
of powders, and some are present in 
cheeses, sugars and powdered milks 
[53,54]. Overall, intake of dietary 
inorganic microparticles in the UK has 
been estimated to be about 40 
mg/person/day (w35 mg for the silicates 
and w5 mg for titanium dioxide) which 
equates to a staggering daily exposure of 
1012-14 particles/person  [55]. Therefore, 
the gastrointestinal tract is regularly 
exposed to significant, milligram 
quantities of nanoparticles and 
microparticles (100–3000 nm) per day, 
including silicates and TiO
2
 [54], contained 
in food, toothpaste and atmospheric 
sources. Following oral delivery, ‘solid’ 
particles (e.g. 50–100 nm polystyrene) can 
be actively transferred to the blood and 
lymphatic system and reach the liver and 
spleen [56].  
Currently, there is only a small amount of 
literature that exists concerning the 
effects of nanoparticles on the 
gastrointestinal tract, most of which is 
contradictory. The upper aero-digestive 
tract, i.e., the nose and the oral cavity, on 
the one hand, acts as a complex barrier. 
Recently a buccal physicological in vitro 
system was developed using oral mucosa 
tissue with a Franz diffusion cell. In 
combination with human oral squamous 
epithelial cells (the H376 cell line) this 
system offers a valuable tool to evaluate 
the behaviour of nanomaterials in the 
buccal mucosa [57]. 
An evolving interest is ongoing however in 
studying nanomaterial interactions with 
the gastrointestinal tract in vitro such as 
the colonic carcinoma cell line, Caco-2 
[58,59], which has differentiated features 
consistent with small intestinal 
enterocytes. During the last years many 
co-culture systems of the intestine have 
been developed and they will be described 
in more detail (see paragraph 3.1). 
As an ex-vivo system the Ussing chamber 
has been described to provide a short-
term organ culture method to study 
transport parameters of intact intestinal 
epithelium (for a review of the technique 
see Clarke, 2009 [60]) (. Only few studies 
have been found who have applied this 
method to assess nanoparticle apparent 
permeability across the epithelium [61,62] 
Since those studies aimed to develop drug 
carrier system the comparision with cell 
culture studies with the focus on basic 
nanoscience is difficult. 
 
 
 

ht
tp
://
do
c.
re
ro
.c
h
2.3. Epithelial lung cell culture 
models 
Not only oxygen is inhaled but with every 
breath we take, millions of (nano)particles 
enter the respiratory system. The 
deposition of particles in the lung is size 
dependent [63,64].  Nanomaterials can be 
released into the environment from 
combustion-derived processes, or, in an 
occupational setting, by the use of 
nanomaterial-containing consumer 
products, such as aerosol sprays. Besides 
the geometry of the airways and the 
breathing pattern, the specific particle size 
is important for studying the deposition 
and clearance of particles in the 
respiratory tract. Following inhalation, 
airborne particles deposit in the different 
regions of the respiratory tract in a size-
dependent manner [63,64]. Larger 
particles (1-10 ʅm) preferentially deposit 
in lager conducting airways (trachea, 
bronchi), whereas smaller particles (i.e. 
NPs) localize to more peripheral lung 
regions (alveoli) [4]. Once deposited, 
particles interact with the pulmonary 
surfactant and are displaced via wetting 
forces into the aqueous hypophase [65], 
where they can interact with pulmonary 
epithelial cells [66]. 
Because the lung is considered by far the 
most important portal of entry for 
nanomaterials into the human body, a lot 
of studies have been performed using 
epithelial lung cell culture models. The 
complex nature of the lung architecture 
means that the epithelium from the upper 
and the lower airways as well as from the 
alveoli is not readily accessible. Therefore, 
the use of in vitro cultures of airway and 
alveolar cells as a reliable tool for in vitro 
models to study the potential toxicity of 
nanomaterials has gained great interest 
during the last decade. Only if adequate 
characterisation and validation is 
performed, such systems may be valuable 
alternatives to inhalation experiments 
using animal testing strategies. 
 
2.3.1. Airway epithelial cell cultures 
The surface of the airways is lined by a 
pseudo-stratified epithelium. At the air-
interface predominantly ciliated columnar 
cells lay interspersed with mucous goblet 
cells in the upper airways and cuboidal 
ciliated cells interspersed with the 
secretory active Clara cells in the lower 
airways [67,68].  
Although primary cultures of tracheal and 
bronchial epithelial cells are technically 
feasible [69,70] a number of studies have 
been done using cell lines. Among them, 
the most popular human airway epithelial 
cell lines are the Calu-3 and the 
16HBE14o-. The Calu-3 cell line is of 
human origin, commercially available from 
the American Type Culture Collection, and 
displays epithelial morphology as well as 
adherent growth. The presence of tight 
junctions and the secretory activity makes 
the Calu-3 cell line a promising tool for 
pulmonary drug absorption studies [71]. 
The immortalized 16HBE14o- cell line, a 
SV-40 large T-antigen transformed 
bronchial epithelial cell line, is a normal 
human airway epithelial cell line and only 
available as a gift from Dieter Gruenert 
(Cardiovascular Research Institute, 
University of California, San Francisco). 
The cells form polarized monolayers 
(Figure 3) with extensive tight junction 
belts [31,71] and when the cells are grown 
on collagen-supports at an air-liquid 
interface they retain important properties 
of differentiated airway epithelial cells  
[72]. 

Figure 3: PhaseͲcontrast micrographs of 16HBE14oͲ
epithelialcellculturesafter4daysinculture.A)andB)
represent images taken at different magnifications
(10x and 40x, respectively). The cells formed a tight
andconfluentmonolayer.
The BEAS-2B cell line was derived from 
normal human epithelial cells 
immortalized using the adenovirus 12-
simian virus 40 hybrid virus [73] and is 
available from the American Type Culture 
Collection. These cells have been often 
used to study airway epithelial structure 
and function, although they do not form 
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tight junctions (for a review see Forbes 
[74]). 
All of these 3 cell lines are often used to 
assess particle cell interactions [26], and 
to study the potential toxicity of 
nanoparticles [75,76]. 
Pig trachea can be easily obtained from 
the slaughterhouse and used for several 
hours as an easy ex-vivo system to study 
effects of nanomaterial shape, size and 
charge on mucociliary clearance [77] and 
further studies with this system should be 
emphasized.  
 
2.3.2. Alveolar epithelial cell cultures  
Primary alveolar epithelial cell cultures 
provide a tight epithelial barrier 
resembling the pulmonary barrier in vivo. 
It has been described that human alveolar 
epithelial type II cells isolated from normal 
human lung tissue undergo morphological 
and histochemical changes, differentiating 
from type II to type I like cells [30]. In case 
alveolar epithelial cell cultures are used 
for in vitro drug transport studies a high 
trans-epithelial electrical resistance is a 
pre-requisite and it has been shown that in 
primary cultures of isolated alveolar type II 
cells, monolayers with high trans-epithelial 
electrical resistance (>1000cm2) can be 
generated [30,78]. 
In contrast to primary cells, cell lines are 
often preferred due to the ease of cell 
culture and the purity of cell types. The 
cell line A549, which originates from 
human lung carcinoma [79], belongs to 
the most well characterized and most 
widely used in vitro models [80]. It is also 
available from the American Type Culture 
Collection. It has been shown that the 
A549 cells have many important biological 
properties of alveolar epithelial type II 
cells (e.g. membrane-bound inclusions), 
which resemble lamellar bodies of type II 
cells [81]. Other ultra-structural 
characteristics that are common to type II 
epithelial cells have also been described, 
as for example distinct polarisation, tight 
junctions, and extensive cytoplasmic 
extensions [88]. Contradictory results 
concerning the capability of this cell line 
to express tight junctions and to generate 
trans-epithelial electrical resistance have 
been published. We have shown that trans-
epithelial electrical values between 140 
and 180 :cm2 have been developed and 
remained stable from day 3 to day 12. 
Elbert and colleagues [30] found that 
A549 cells did not express Zonula 
occludens-1, an intracellular protein of the 
tight junction complex. We were also not 
able to detect Zonula occludens-1 when 
assessed via inmmunofluorescence. 
However, we did find that A549 cells are 
positive for Zonula occludens-3, occludin 
and also claudin-2 [89,90]. Comprising a 
comparison between the different 
published results is extremely difficult 
since in the Elbert study the A549 cells 
were used between passage 88-95 and 
after cells were grown to confluent 
monolayers. In our study the cells were 
used for 10-70 passages and kept in 
culture for a minimum of 7 days. Since it 
has been shown for other epithelial cell 
lines that various factors influence the 
growth and appearance [33] it is very 
important to evaluate the cells under 
strictly controlled conditions. Thus, it is 
the opinion of the authors that when using 
A549 cells under controlled conditions 
they are an appropriate epithelial alveolar 
model.  
In addition, the A549 cells have already 
been used not only to assess acute effects 
but to study possible adaptive 
mechanisms during long-term 
consequences [82]. This is an important 
aspects since humans have to deal with 
chronic exposures to ambient 
nanoparticles as well as chronic 
occupational exposure to engineered 
nanomaterials at the workplace and needs 
to be studied in the future in more detail. 
Just recently, the immortalization of 
human type II cells for the use in 
nanotoxicity studies has been reported by 
Kemp and co-workers. This new cell line 
exhibited a type I like phenotype, no 
longer expressed alkaline phosphatase 
and pro surfactant protein C, but showed 
enhanced levels of caveolin-1 and RAGE 
(receptor for advanced glycation 
endproducts). The uptake of latex 
particles was studied with these cells and 
the cell line was postulated to be 
important for particle translocation 
studies [83]. 
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 2.3.3. Air-liquid cultures 
The cultivation of epithelial cells on 
permeable supports enables the culture 
medium to be separated on either side of 
the cultured epithelium leading to an 
increased differentiation of the cultured 
cells [84]. Furthermore, the medium can 
be removed from the upper side to expose 
the cells to air on one side, allowing the 
cells to ‘feed’ from the medium in the 
chamber underneath [85,86]. The air-
liquid culture technique has been 
described in different cell culture models 
[87-89]. Air-exposed cell cultures allow 
studying the interaction of inhaled 
nanomaterials with cells in an environment 
that more closely mimics the in vivo 
situation. Of particular importance is that 
the cells are covered by a very thin liquid 
lining layer with a molecular surfactant 
film at the air-liquid interface since 
surfactant plays an important role in 
particle displacement and retention [90]. 
In recent nanoparticle-cell interaction 
studies air-exposed A549 cells were used 
and exposed to air and the test 
substances simultaneously [91,92]. 
However, the cells need time to release 
the surfactant into the liquid layer [93]. 
Also the bronchial epithelial cell line 
16HBE14o- as well as Calu-3 cells can be 
exposed to air [94]. In these studies the 
air-exposed cultures exhibited a clear 
epithelial morphology and integrity as in 
in situ conditions. Such in vitro cell 
systems combined with various air-liquid 
exposure systems that allow a 
dosimetrically accurate delivery of 
aerosolized nanomaterial offer a reliable 
method for the investigation of 
nanomaterial-cell interactions and possible 
cellular responses (for reviews see 
[20,95]). 
 
3. Co- culture models
Studies have shown that when cells are 
removed from their host tissue and are 
grown as monolayers on impermeable 
surfaces, they undergo dedifferentiation 
and lose specialized functions, which is 
thought to be, in part, due to the 
disassociation of cells from their native 
three-dimensional (3D) tissue structure in 
vivo [24]. During the last years it has been 
recognized that not only the three 
dimensional structure seems to be 
important for the differentiation of certain 
cells [96] but also the culturing of 
different cells together is an important 
issue. Not only is 3D structure important, 
but also co-cultures of different cell types 
have been shown to have an influence on 
the outcome of the results, since cells 
continuously cross-talk in vivo through 
intercellular signalling to maintain 
homeostasis and to coordinate immune 
responses [97].  
 
3.1. Intestine mucosa 
To study the interaction of dendritic cells 
with gut epithelial cells during the process 
of particle sampling, a co-culture system 
was developed using the human 
enterocyte cell line caco-2 combined with 
bone marrow-derived dendritic cells 
[98,99]. Another co-culture system of the 
gut mucosa was recently developed by 
using Caco-2 cells that are cultured in 
close contact with Raij-B-cells (B 
lymphocytes). During co-culture 15 to 30 
% of the Caco-2 cells are converted into M-
cells which are differentiated epithelial 
cells, specialised in the transcytosis of 
macromolecules and particles across the 
gastro-intestinal tract [100,101].  
Of interest is also if diseased tissue reacts 
more susceptible than healthy tissue to 
the exposure of nanomaterials. To reveal 
more insights into this, a complex in vitro 
model of the inflamed intestinal mucosa 
has been developed composed of Caco2 
enterocytes, macrophages and dendritic 
cells. By applying fluorescently labelled 
particles to the co-cultures they found 
significantly more nanoparticles adhered 
to inflamed cells compared to the non-
stimulated control [102]. Further studies 
need to be done to evaluate the 
differences between mono- and co-
cultures. 
 
3.2.  Lung mucosa 
So far, in vitro co-cultures to mimic the 
alveolar epithelial barrier with two cell 
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types have been described in the 
literature. Two cell co-culture models with 
epithelial (A549 cells) and endothelial cells 
were established to examine events in the 
pathogenesis of bacteria [103,104]. 
Recently, a primary co-culture system to 
simulate the human alveolar-capillary 
barrier by using primary cells was 
developed. Human pulmonary 
microvascular endothelial cells were co-
cultivated with primary isolated human 
type II alveolar epithelial cells on opposite 
sides of a permeable filter support, to 
study the impact of nanocarriers 
[105,106]. 
Recently we developed a triple cell culture 
in vitro model of the human airway wall to 
study the cellular interplay and the cellular 
response of epithelial cells, human blood 
monocytes derived macrophages and 
dendritic cells to particles [107]. In this 
model, monolayers of two different 
epithelial cell lines, A549 [34] and 
16HBE14o- epithelia [26] as well as 
primary epithelial type I cells [108] can be 
grown on a microporous membrane in a 
two chamber system. In addition, a 
quadruple-culture containing epithelial, 
endothelial, macrophages as well as mast 
cells has been established [109]. Studies 
using such co-culture cell systems have 
reported that they observe different 
reactions compared to monoculture 
analysis when the cells were exposed to 
nanomaterials [27,110]; however, such 
reactions observed from a culture 
containing two, three or four different 
types of cells merely cultured in the same 
dish, is not specific to that as it would 
occur in the human body. Thus, the 
architecture of the in vitro cell co-culture 
model in regard to the specific organ they 
represent is essential when nanomaterials 
effects are studied. 
 
4. Nanomaterial- epithelial cell 
interactions: Biological 
mechanism and responses
Epithelial cell systems in vitro have 
become an important tool for the study of 
biological mechanism upon nanomaterial 
exposure as well as a pre-screening 
system for nanomaterial risk assessment. 
A complete overview about nanomaterial 
uptake mechanism and induction of cell 
responses is however beyond the remit of 
this review article and for a clear 
understanding in these fields it is 
suggested that other publications are 
considered.  
Briefly, different uptake mechanisms of 
nanomaterials into cells and intracellular 
trafficking described so far have been 
discussed in detail by various reviews 
[66,111-113]. Depending on size, shape, 
material and coating of the material and 
the cell type possible uptake can occur by 
phagocytosis, macropinocytosis, clathrin- 
and caveolae-mediated endocytosis, 
clathrin and caveolae independent 
endocytosis and nanomaterial diffusion / 
transport across the cell plasma 
membrane. In addition it has been shown 
that the kinetics of all known processes 
depends largely on nanomaterial surface 
as well as on in vivo surface modifications 
such as interactions wih endogenous 
proteins [4].  
Once inside the cells, nanomaterials may 
cause several biological responses 
including the generation of reactive 
oxygen species [114], the enhanced 
expression of pro-inflammatory cytokines 
[115], and DNA strand breaks [116]. 
However, the precise mechanism of 
possible nanomaterial toxicology is still 
not fully understood [19]. Currently, the 
hypothesis that nanomaterials induce 
adverse cellular effects via oxidative 
means (oxidative stress paradigm) [117] is 
used as a basis for many nanomaterial-
based investigations. Recently, additional 
paradigms have been suggested for 
nanomaterials, such as the fibre paradigm 
[118] and the theory of genotoxicity [119]. 
In addition, some important aspects about 
the use of reliable methods and realistic 
test conditions to study possible risks of 
nanomateriales have recently been 
reviewed in several publications. For 
instance the in-depth characterization of 
the nanomaterial, the use of suspension 
versus air-liquid exposures, the use of 
realistic doses, and the validity of the 
selected test methods have been 
highlighted [95,120]. 
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5. Conclusions
There is an ascertainable trend towards 
the development of more predictive and 
reliable in vitro testing systems using 
smart biotechnology to reduce time and 
cost investments. The discussed epithelial 
cell culture models may help to elucidate 
the mechanism of how nanomaterials can 
interact with cells, the primary barrier 
system encountered following exposure of 
nanomaterials by ingestion, inhalation and 
application to the skin. Even though 
epithelial cell culture models exhibit a 
number of limitations, they can be used 
for high-throughput screening and the 
screening of large numbers of newly 
developed nanomaterials and to study 
basic nanomaterial-cell interactions, such 
as uptake and induction of cellular 
responses. An essential disadvantage is, 
however, that the complex environment 
cannot be satisfactorily been reproduced 
since cell culture models often do not 
exhibit all the differentiated and 
functional characteristics of the 
corresponding native epithelium or the 
entire organ. Finally, any model needed to 
study the epithelium for a certain question 
should be selected very carefully, 
considering its limitations and taking 
these limitations into account for the 
experimental design and the 
interpretation of the results. 
For studies with skin-models it seems to 
be feasible to use skin-tissue from 
animals, i.e. pigs, which can directly be 
obtained in the slaughterhouse. The use 
of cell cultures to mimic the gastro-
intestinal or lung tissue helps to evaluate 
basic mechanisms such as nanomaterial-
cell interactions or induction of cellular 
responses. However, this might not be 
sufficiently covered by only performing 
monoculture analysis and for both tissues 
there are sophisticated co-culture models 
available mimicking more realistically the 
specific organs. Table 1 summarizes the 
epithelial cell culture models discussed in 
this review. Considering the attempts to 
initiate the reduction, refinement and 
replacement of in vivo experimental 
approaches, many in vitro epithelial cell 
culture models have been developed 
during the last decades.  By using well 
defined in vitro approaches combined with 
a controlled nanomaterial exposure such 
systems are of great importance to help 
understanding how nanomaterials interact 
with living matter. 
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 Table
Table 1:  Human epithelial cell lines mimicking primary exposure barriers. This table only 
represents a selection of available cell lines. 
Skin epithelial cell lines  References 
x Keratinocyte cell line HaCaT [49-51] 
x Epidermal cell line A431 [47] 
Gastro- intestinal tract epithelial cell lines   
x Oral squamous cell line H376 [57] 
x Intestine cell line Caco2 [58,59] 
Lung epithelial cell lines  
Airway epithelial cells  
x Calu-3 [71,88,121-123] 
x 16HBE14o- [26,27,74,88] 
x BEAS-2B [75,76] 
Alveolar epithelial cells  
x A549 [34,80,82,93] 
x Immortalized human alveolar type 2 cells with alveolar 
type 1 phenotype 
[83] 
Co- Cultures  
Gastro-intestintal tract  
x Co-cultures of Caco2 with dendritic cells [98,99] 
x Co-cultures of Caco2 with Rauj-B-cells [100,101] 
Lung  
x Co-cultures of A549 with endothelial cells [103,124] 
x Triple cell co-culture model (epithelial cells, 
macrophages, dendritic cells) 
[26,34] 
x Quadruple co-culture model with epithelial, 
endothelial, mast cells and macrophages 
[109] 
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